Adagio Medical Holdings, Inc.
ADGM· Nasdaq
ADGMAdagio Medical Holdings, Inc.
Filed Aug 11, 2026 · 10-Q · 42 days after period end · 0001104659-26-093790
| Metric | Q2 2026 | Q2 2025 | Q2 2024 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $254.00K |
| Net Income | -$6.72M | -$3.95M | -$5.73M |
| EPS Diluted | -$0.30 | -$0.35 | -$7.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adagio Medical Holdings, Inc. · CIK 2006986 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 11, 2026 · 42 d after period end
